2023-10-01 06261518 2024-09-30 06261518 2023-10-01 2024-09-30 06261518 2023-09-30 06261518 2022-10-01 2023-09-30 06261518 uk-core:WithinOneYear 2023-09-30 06261518 uk-core:WithinOneYear 2024-09-30 06261518 uk-core:AfterOneYear 2023-09-30 06261518 uk-core:AfterOneYear 2024-09-30 06261518 uk-core:ShareCapital 2024-09-30 06261518 uk-core:ShareCapital 2023-09-30 06261518 uk-core:RetainedEarningsAccumulatedLosses 2024-09-30 06261518 uk-core:RetainedEarningsAccumulatedLosses 2023-09-30 06261518 uk-bus:Director1 2023-10-01 2024-09-30 06261518 uk-core:ToolsEquipment 2023-10-01 2024-09-30 06261518 uk-core:MotorVehicles 2023-10-01 2024-09-30 06261518 uk-core:FurnitureFittings 2023-10-01 2024-09-30 06261518 uk-core:Goodwill 2023-09-30 06261518 uk-core:Goodwill 2024-09-30 06261518 uk-core:ToolsEquipment 2023-09-30 06261518 uk-core:FurnitureFittings 2023-09-30 06261518 uk-core:MotorVehicles 2023-09-30 06261518 uk-core:LandBuildings 2023-09-30 06261518 uk-core:LandBuildings 2023-10-01 2024-09-30 06261518 uk-core:MotorVehicles 2024-09-30 06261518 uk-core:FurnitureFittings 2024-09-30 06261518 uk-core:ToolsEquipment 2024-09-30 06261518 uk-core:LandBuildings 2024-09-30 06261518 uk-core:WithinOneYear uk-core:Secured 2024-09-30 06261518 uk-core:WithinOneYear uk-core:Secured 2023-09-30 iso4217:GBP xbrli:pure 06261518 uk-bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 06261518 uk-bus:FRS102 2023-10-01 2024-09-30 06261518 uk-bus:FilletedAccounts 2023-10-01 2024-09-30 06261518 uk-bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30
Drugmart Limited
Registered Number:06261518
For the year ended 30 September 2024
England and Wales
Unaudited Financial Statements
2
For the year ended 30 September 2024
Drugmart Limited
Contents Page
1
Statement of Financial Position
2 to 5
Notes to the Financial Statements
3
Registered Number :
06261518
As at 30 September 2024
Drugmart Limited
Statement of Financial Position
£
£
2023
2024
Notes
Fixed assets
Intangible assets
425,000
425,000
2
Property, plant and equipment
135,749
139,319
3
560,749
564,319
Current assets
Inventories
98,562
108,497
4
Trade and other receivables
250,777
253,973
5
108,017
Cash and cash equivalents
92,393
454,863
457,356
Trade and other payables: amounts falling due within one
year
(422,050)
(452,977)
6
35,306
1,886
Net current assets
Total assets less current liabilities
562,635
599,625
Trade and other payables: amounts falling due after more
than one year
(596,275)
(558,087)
7
(2,998)
(845)
Provisions for liabilities
1,550
Net assets
2,505
Capital and reserves
Called up share capital
100
100
Retained earnings
1,450
2,405
1,550
2,505
Shareholders' funds
For the year ended 30 September 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006
The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Section
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
1 of 5
4
Registered Number :
06261518
For the year ended 30 September 2024
Drugmart Limited
Statement of Financial Position Continued
Muhammad Irfan Motala Director
These financial statements were approved and authorised for issue by the Board on 18 February 2025 and were signed by:
The notes form part of these financial statements
2 of 5
5
For the year ended 30 September 2024
Drugmart Limited
Notes to the Financial Statements
Statutory Information
Drugmart Limited is a private limited company, limited by shares, domiciled in England and Wales, registration number
06261518.
Registered address:
78 Spotland Road
Rochdale
Lancashire
OL12 6PQ
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial
Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the
Companies Act 2006. The financial statements have been prepared under the historical costs convention as
modified by the revaluation of certain assets.
Revenue recognition
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Property, plant and equipment
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
33 Straight line
Computer equipment
25 Straight line
Motor vehicles
10 Straight line
Fixtures and fittings
No depreciation is provided on the company''s freehold properties since in the opinion of the directors the expected
useful lives are sufficiently long and the estimated residual values are sufficiently high that any such depreciation
would be immaterial. The directors undertake an annual impairment review of these properties.
Inventories
Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow moving items. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.
Hire purchase and leasing commitments
Rentals payable under operating leases are charged against income on a straight line basis over the lease term.
3 of 5
6
For the year ended 30 September 2024
Drugmart Limited
Notes to the Financial Statements Continued
2. Intangible fixed assets
Goodwill
Cost or valuation
£
At 01 October 2023
425,000
At 30 September 2024
425,000
Net book value
At 30 September 2024
425,000
At 30 September 2023
425,000
3. Property, plant and equipment
Total
Computer
equipment
Fixtures and
fittings
Motor vehicles
Land and
buildings
£
£
£
£
£
Cost or
valuation
At 01 October 2023
208,171
5,036
83,556
2,450
117,129
3,622
3,622
-
-
-
Additions
At 30 September 2024
2,450
83,556
8,658
211,793
117,129
Provision for depreciation and impairment
At 01 October 2023
68,852
5,036
62,266
1,550
-
Charge for year
7,192
1,195
5,507
490
-
At 30 September 2024
76,044
6,231
67,773
2,040
-
At 30 September 2024
Net book value
117,129
410
15,783
2,427
135,749
At 30 September 2023
117,129
900
21,290
-
139,319
4. Inventories
2023
2024
£
£
Stocks
108,497
98,562
5. Trade and other receivables
2023
2024
£
£
Trade debtors
-
237
Other debtors
253,973
250,540
250,777
253,973
4 of 5
7
For the year ended 30 September 2024
Drugmart Limited
Notes to the Financial Statements Continued
6. Trade and other payables: amounts falling due within one year
2023
2024
£
£
Bank loans and overdraft (secured)
45,000
43,333
Trade creditors
297,029
332,896
Taxation and social security
13,926
17,221
Other creditors
97,022
28,600
452,977
422,050
7. Trade and other payables: amounts falling due after more than one year
2023
2024
£
£
Bank loans and overdraft (secured)
350,445
396,275
Other creditors
207,642
200,000
558,087
596,275
8. Average number of persons employed
During the year the average number of employees was 20 (2023 : 16)
5 of 5